Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-015888

Options or other derivatives

  • Chief Medical Officer acquired 82,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gordon David N. · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-01 Grant or award : show line 1 in the form Restricted stock units +82,400 82,400 D
Loading xslF345X03/doc4.xml…